跳至主要内容
临床试验/EUCTR2009-013643-11-IT
EUCTR2009-013643-11-IT进行中(未招募)不适用

europrotective effects of palmitoylethanolamide in diabetic neuropathy: a pilot study. - palmitoylethanolamide (PEA) - diabetic neuropathy

ISTITUTO NEUROLOGICO CARLO BESTA0 个研究点开始时间: 2009年7月24日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • ? caucasian male or female
  • ? aged 18 to 75 years inclusive
  • ? clinical diagnosis of diabetic neuropathy
  • ? an IENF density at Screening Visit ≤ 5 at distal leg
  • ? written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • ? patients with neuropathy due to possible other causes
  • ? patients affected by psychiatric disorders
  • ? pregnant or lactating women
  • ? subjects with history of alcohol or drug abuse
  • ? subjects who have received an experimental drug or have participated in a clinical
  • trial within 3 month prior to screening
  • ? employees of the investigator or study centre with direct involvement in the proposed study or other studies under the direction of that investigator or study

研究者

发起方
ISTITUTO NEUROLOGICO CARLO BESTA

相似试验